Congressional Testimony

• December 13, 2005
  Robert J. Meyer, M.D.
  Director of the Office of New Drug Evaluation II
  Subject: Hearing on FDA’s Role in Regard to Controlled Substances
  Before: Subcommittee on Oversight and Investigations
  
  
• November 1, 2005
  Randall W. Lutter, Ph.D.
  Acting Associate Commissioner for Policy and Planning
  Subject: Hearing on Counterfeit Drugs within the United States
  Before: Subcommittee on Criminal Justice
  
  
• September 29, 2005
  Rachel E. Behrman, M.D., M.P.H.
  Deputy Director, Office of Medical Policy
  Subject: The Impact of Direct-to-Consumer Drug Advertising on Seniors' Health and Health Care Costs
  Before: Special Committee on Aging
  
  
• September 13, 2005
  Robert J. Meyer, M.D.
  Director, Office of Drug Evaluation II
  Subject: Prescription Drug Abuse
  Before: Committee on Government Reform
  
  
• September 7, 2005
  Richard Pazdur, M.D.
  Director, Office of Oncology Drug Products
  Subject: Women and Gynecologic Cancers
  Before: Committee on Government Reform
  
  
• July 20, 2005
  Robert E. Brackett, Ph.D.
  Director Center for Food Safety and Applied Nutrition
  Subject: Counterterrorism Activities
  Before: Committee for Agriculture, Nutrition and Forestry, United States Senate
  
  
• June 14, 2005
  Robert E. Brackett, Ph.D.
  Director Center for Food Safety and Applied Nutrition
  Subject: Bioengineered Foods
  Before: Committee for Agriculture, Nutrition and Forestry, United States Senate
  
  
• May 17 , 2005
  Robert E. Brackett, Ph.D.
  Director Center for Food Safety and Applied Nutrition
  Subject: Food Supply
  Before: Before the Committee on Goverment Reform
  
  
• May 5 , 2005
  Steven Galson, M.D., M.P.H.
  Acting Director, Center for Drug Evaluation and Research
  Subject: Drug Safety
  Before: Before the Committee on Goverment Reform
  
  
• May 4 , 2005
  Jesse L. Goodman, M.D., M.P.H.
  Director, Center for Biologics, Evaluation and Research
  Subject: Influenza Vaccine Supply
  Before: Before the Committee on Energy and Commerce
  
  
• March 17 , 2005
  Lester M. Crawford, D.V.M., Ph.D.
  Acting Commissioner of Food and Drugs
  Subject: Confirmation Statement
  Before: Committee on Health, Education, Labor and Pensions
  
  
• March 1 & 3, 2005
  Sandra L. Kweder, M.D. and Janet Woodcock, M.D.
  Subject: Drug Safety
  Before: Committee on Health, Education, Labor and Pensions
  
  
• February 10, 2005
  Jesse L. Goodman, M.D., M.P.H.
  Director, Center for Biologics Evaluation and Research
  Subject: Influenza Vaccine: Current Status, Lessons Learned and Preparing for the Future
  Before: Committee on Government Reform, United States House of Representatives